B2M and neoplasm: The final multi-omics model incorporated the following 10 initial genomic and transcriptomic biomarkers: response pathway, nsTMB, HED, fsIndel burden, defects in B2M, HLA-B27 supertype, tumor purity, TCR α chain entropy, IFNG-IMS ratio, and IGH entropy.